Mild cognitive impairment is not a clinical entity and should not be treated - PubMed (original) (raw)

. 2005 Jul;62(7):1164-6; discussion 1167.

doi: 10.1001/archneur.62.7.1164.

Affiliations

• PMID: 16009780
• DOI: 10.1001/archneur.62.7.1164

Mild cognitive impairment is not a clinical entity and should not be treated

Serge Gauthier et al. Arch Neurol. 2005 Jul.

No abstract available

PubMed Disclaimer

Comment in

• Mild cognitive impairment as a clinical entity and treatment target.
  Petersen RC, Morris JC. Petersen RC, et al. Arch Neurol. 2005 Jul;62(7):1160-3; discussion 1167. doi: 10.1001/archneur.62.7.1160. Arch Neurol. 2005. PMID: 16009779 Review. No abstract available.

Similar articles

• Mild cognitive impairment as a clinical entity and treatment target.
  Petersen RC, Morris JC. Petersen RC, et al. Arch Neurol. 2005 Jul;62(7):1160-3; discussion 1167. doi: 10.1001/archneur.62.7.1160. Arch Neurol. 2005. PMID: 16009779 Review. No abstract available.
• [Mild cognitive impairment].
  Schmidt R. Schmidt R. Wien Klin Wochenschr. 2005 Sep;117(18):617-9. doi: 10.1007/s00508-005-0411-2. Wien Klin Wochenschr. 2005. PMID: 16416342 German. No abstract available.
• [What is a mild cognitive impairment?].
  Portet F, Ousset PJ, Touchon J. Portet F, et al. Rev Prat. 2005 Nov 15;55(17):1891-4. Rev Prat. 2005. PMID: 16396229 Review. French.
• A clinical perspective of mild cognitive impairment: what radiologists should know.
  Duara R, Loewenstein D, Barker WW, Isaacson RS, Greig-Custo M. Duara R, et al. Neuroimaging Clin N Am. 2005 Nov;15(4):779-88, x. doi: 10.1016/j.nic.2005.09.010. Neuroimaging Clin N Am. 2005. PMID: 16443490 Review.
• Mild cognitive impairment: a concept ready to move on?
  Forlenza OV, Chiu E. Forlenza OV, et al. Curr Opin Psychiatry. 2008 Nov;21(6):529-32. doi: 10.1097/YCO.0b013e328316c2ab. Curr Opin Psychiatry. 2008. PMID: 18852557 No abstract available.

Cited by

• Mild cognitive impairment in Parkinson disease: heterogenous mechanisms.
  Jellinger KA. Jellinger KA. J Neural Transm (Vienna). 2013 Jan;120(1):157-67. doi: 10.1007/s00702-012-0771-5. Epub 2012 Feb 18. J Neural Transm (Vienna). 2013. PMID: 22350538 Review.
• Selectivity of executive function deficits in mild cognitive impairment.
  Brandt J, Aretouli E, Neijstrom E, Samek J, Manning K, Albert MS, Bandeen-Roche K. Brandt J, et al. Neuropsychology. 2009 Sep;23(5):607-18. doi: 10.1037/a0015851. Neuropsychology. 2009. PMID: 19702414 Free PMC article.
• Reappraisal of the Concept of Accelerated Aging in Neurodegeneration and Beyond.
  Statsenko Y, Kuznetsov NV, Morozova D, Liaonchyk K, Simiyu GL, Smetanina D, Kashapov A, Meribout S, Gorkom KN, Hamoudi R, Ismail F, Ansari SA, Emerald BS, Ljubisavljevic M. Statsenko Y, et al. Cells. 2023 Oct 14;12(20):2451. doi: 10.3390/cells12202451. Cells. 2023. PMID: 37887295 Free PMC article. Review.
• Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.
  Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H. Chertkow H, et al. CMAJ. 2008 May 6;178(10):1273-85. doi: 10.1503/cmaj.070797. CMAJ. 2008. PMID: 18458258 Free PMC article. Review.
• Cholinesterase inhibitors: drugs looking for a disease?
  Maggini M, Vanacore N, Raschetti R. Maggini M, et al. PLoS Med. 2006 Apr;3(4):e140. doi: 10.1371/journal.pmed.0030140. Epub 2006 Apr 11. PLoS Med. 2006. PMID: 16597173 Free PMC article. Review.

MeSH terms

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Silverchair Information Systems